Endoscopic vs. Laparoscopic Resection for Small Gastrointestinal Stromal Tumors: What the Research Says

0
0
0

Endoscopic vs. Laparoscopic Resection for Small Gastrointestinal Stromal Tumors: What the Research Says

If you or a loved one has been diagnosed with a small gastrointestinal stromal tumor (GIST)—a common type of digestive tract tumor—you may be weighing two minimally invasive treatment options: endoscopic resection (a thin tube inserted through the mouth) or laparoscopic surgery (small incisions in the abdomen). Which is better? A 2020 cumulative meta-analysis published in the Chinese Medical Journal helps answer this question by combining data from 12 studies involving over 1,300 patients.

What Are GISTs?

GISTs are the most common mesenchymal (connective tissue) tumors of the digestive system, with 60–70% occurring in the stomach. While tumors larger than 2 cm are typically recommended for removal (due to their potential to become cancerous), even smaller GISTs can have high mitotic activity (a sign of rapid cell growth). For years, open surgery was the standard, but minimally invasive techniques like endoscopic resection (ER) and laparoscopic resection (LAP) have revolutionized care. However, their effectiveness compared to each other has been debated—until now.

The Study: Combining Data for Clarity

Led by researchers from Ningbo Medical Center Lihuili Hospital and Zhejiang University (China), the study analyzed 12 high-quality cohort studies comparing ER (including techniques like endoscopic full-thickness resection [EFR], endoscopic submucosal dissection [ESD], and submucosal tunneling endoscopic resection [STER]) to LAP for GISTs ≤5 cm. They also looked at 3 studies comparing ER to laparoscopic-endoscopic cooperative surgery (LECS), a newer approach that combines endoscopy (for precision) and laparoscopy (for safety).

The analysis followed strict guidelines (registered on PROSPERO: CRD42020167417) and used statistical tools like meta-regression (to check for bias from tumor size) and cumulative meta-analysis (to track how results changed over time) to ensure reliability.

Key Findings: ER vs. LAP

The study found clear advantages for ER—and important caveats:

  1. Faster Procedures & Quicker Recovery
    ER was 27 minutes shorter on average than LAP (weighted mean difference [WMD] = -27.1 minutes) and reduced hospital stays by 1.4 days (WMD = -1.43 days). These results were consistent across studies, meaning ER’s speed and recovery benefits are reliable.

  2. Similar Safety & Cost
    There was no significant difference in:

    • Blood loss (ER vs. LAP: WMD = -9.2 mL, nearly identical).
    • Hospitalization costs (ER was slightly cheaper, but not statistically significant).
    • Complications (e.g., bleeding, perforation) or recurrence rates (both methods had similar long-term outcomes).

  3. Critical Warning for Larger Tumors
    For GISTs between 2–5 cm, ER was 5.78 times more likely to leave positive margins (cancer cells at the edge of the removed tissue) compared to LAP. Positive margins increase the risk of recurrence, so this is a major concern for larger tumors.

ER vs. LECS: A Newer Option

LECS—where endoscopists and laparoscopic surgeons work together—was compared to ER in 3 studies. The results:

  • ER was faster (41 minutes shorter on average).
  • ER had more complications (4 times higher risk of issues like perforation or bleeding).

LECS combines the precision of endoscopy with the safety of laparoscopy, making it a promising option for complex GISTs—though more research is needed.

What Does This Mean for Patients?

The study cautiously concludes that ER is a viable alternative to LAP for gastric GISTs ≤5 cm (since most data focused on stomach tumors). It’s ideal for patients who want:

  • Faster surgery and recovery.
  • Avoiding abdominal incisions.

But there’s a catch: For GISTs between 2–5 cm, your doctor must carefully assess whether ER can achieve negative margins (no cancer cells left behind). If not, LAP or LECS may be better.

Limitations to Consider

Like all studies, this one has gaps:

  • Observational data: Most studies were retrospective (looking back at past cases), not randomized controlled trials (the “gold standard” for medical research).
  • Gastric focus: Nearly all patients had stomach GISTs—results may not apply to intestinal tumors.
  • LECS data: Only 3 studies compared ER to LECS, so conclusions about LECS are less certain.

The Bottom Line

If you have a small gastric GIST, ER is a safe, effective option—but it’s not one-size-fits-all. Talk to your doctor about:

  • Tumor size (especially if it’s 2–5 cm).
  • Tumor location (ER works best for easily accessible stomach tumors).
  • Your health goals (e.g., prioritizing speed vs. margin safety).

For complex cases, LECS—with its multidisciplinary approach—may offer the best balance of precision and safety.

This article summarizes findings from: Cai XL, Li XY, Liang C, et al. Endoscopic or laparoscopic resection for small gastrointestinal stromal tumors: a cumulative meta-analysis. Chinese Medical Journal 2020;133(22):2731–2742. doi:doi.org/10.1097/CM9.0000000000001069

Was this helpful?

0 / 0